Gatterer, C.; Beitzke, D.; Graf, S.; Lenz, M.; Sunder-Plassmann, G.; Mann, C.; Ponleitner, M.; Manka, R.; Fritschi, D.; Krayenbuehl, P.-A.;
et al. Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease. Life 2023, 13, 1213.
https://doi.org/10.3390/life13051213
AMA Style
Gatterer C, Beitzke D, Graf S, Lenz M, Sunder-Plassmann G, Mann C, Ponleitner M, Manka R, Fritschi D, Krayenbuehl P-A,
et al. Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease. Life. 2023; 13(5):1213.
https://doi.org/10.3390/life13051213
Chicago/Turabian Style
Gatterer, Constantin, Dietrich Beitzke, Senta Graf, Max Lenz, Gere Sunder-Plassmann, Christopher Mann, Markus Ponleitner, Robert Manka, Daniel Fritschi, Pierre-Alexandre Krayenbuehl,
and et al. 2023. "Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease" Life 13, no. 5: 1213.
https://doi.org/10.3390/life13051213
APA Style
Gatterer, C., Beitzke, D., Graf, S., Lenz, M., Sunder-Plassmann, G., Mann, C., Ponleitner, M., Manka, R., Fritschi, D., Krayenbuehl, P. -A., Kamm, P., Dormond, O., Barbey, F., Monney, P., & Nowak, A.
(2023). Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease. Life, 13(5), 1213.
https://doi.org/10.3390/life13051213
